BHI Stem Cells conducted more than 4000 stem cell treatments. Our key customers include patients with a wide variety of medical conditions in which there are no other alternative treatments as well as patients who wish to forego traditional surgical or pharmacologic pathways.
BHI Stem Cells has conducted clinical investigations in collaboration with local partners in Slovakia and China, to evaluate the safety and efficacy of adult stem cells as a regenerative medicine for use in the treatment of chronic inflammation, musculoskeletal conditions, stroke, spinal cord injury and other medical conditions.
In the clinical studies we have taken every precaution to ensure the safety and viability of adult stem cells administered. The results from the clinical studies have provide support for the short and long-term safety of adult stem cell therapies